Adagene Inc.
11Patents
11Active
11Granted
49Portfolio score
Filing activity: Dec 19, 2014 → Jan 11, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11359016B2 | Anti-CTLA4 antibodies and methods of making and using the same | Chemistry; Metallurgy | 4 | Active |
| US11242395B2 | Anti-CD137 molecules and use thereof | Chemistry; Metallurgy | 3 | Active |
| US11585014B2 | Dynamic human antibody light chain libraries | Chemistry; Metallurgy | 2 | Active |
| US11859003B2 | Method for treating cancer using anti-CD137 antibody | Chemistry; Metallurgy | 2 | Active |
| US11952681B2 | Masked activatable CD137 antibodies | Chemistry; Metallurgy | 1 | Active |
| US11578426B2 | Dynamic human heavy chain antibody libraries | Chemistry; Metallurgy | 1 | Active |
| US11485977B2 | Methods and systems for autoinduction of protein expression | Chemistry; Metallurgy | 0 | Active |
| US12054548B2 | Anti-PD-L1 antibodies and use thereof | Physics | 0 | Active |
| US12385162B2 | Dynamic human heavy chain antibody libraries | Chemistry; Metallurgy | 0 | Active |
| US11692036B2 | Anti-CTLA4 antibodies and methods of making and using the same | Chemistry; Metallurgy | 0 | Active |
| US12378319B2 | Anti-CD137 molecules and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.